Page 5 of 6 – SEC Filing Item 3 of the Statement is hereby amended to add the following: On December 22, 2015, the Issuer granted to Kevin C. Tang stock options to purchase an aggregate of 17,000 shares of Common Stock at an exercise price of $29.41 per share. The stock options vest monthly over a one-year period. Tang Capital Partners, LP received $66,035, $67,026, $68,031 and $69,051 principal amount of senior secured convertible notes due 2021 (the “Notes”) on each of July 1, 2015, October 1, 2015, January 1, 2016 and April 1, 2016, respectively, as interest in-kind on the existing Notes held by Tang Capital Partners, LP. Tang Capital Partners, LP holds some of its shares in commingled margin accounts, which may extend margin credit to Tang Capital Partners, LP as and when required to open or carry positions in the margin accounts, subject to applicable federal margin regulations, stock exchange rules and credit policies. In such instances, the positions held in the margin accounts are pledged as collateral security for the repayment of debit balances in these accounts. The margin accounts may from time to time have debit balances. Since other securities are held in the margin accounts, it is not possible to determine the amounts, if any, of margin used to purchase the securities reported herein. Item 5. Interest in Securities of the Issuer
Item 5 of the Statement is hereby amended and restated in its entirety as follows: (a) Amount beneficially owned and percentage of class: Tang Capital Partners, LP 6,117,530 shares, representing 16.3% of the class Tang Capital Management, LLC 6,117,530 shares, representing 16.3% of the class Kevin C. Tang 6,527,743 shares, representing 17.4% of the class
Item 3 of the Statement is hereby amended to add the following:
On December 22, 2015, the Issuer granted to Kevin C. Tang stock options to purchase an aggregate of 17,000 shares of Common Stock at an exercise price of $29.41 per share. The stock options vest monthly over a one-year period.
Tang Capital Partners, LP received $66,035, $67,026, $68,031 and $69,051 principal amount of senior secured convertible notes due 2021 (the “Notes”) on each of July 1, 2015, October 1, 2015, January 1, 2016 and April 1, 2016, respectively, as interest in-kind on the existing Notes held by Tang Capital Partners, LP.
Tang Capital Partners, LP holds some of its shares in commingled margin accounts, which may extend margin credit to Tang Capital Partners, LP as and when required to open or carry positions in the margin accounts, subject to applicable federal margin regulations, stock exchange rules and credit policies. In such instances, the positions held in the margin accounts are pledged as collateral security for the repayment of debit balances in these accounts. The margin accounts may from time to time have debit balances. Since other securities are held in the margin accounts, it is not possible to determine the amounts, if any, of margin used to purchase the securities reported herein.
| Item 5. | Interest in Securities of the Issuer |
Item 5 of the Statement is hereby amended and restated in its entirety as follows:
| (a) | Amount beneficially owned and percentage of class: | |
| Tang Capital Partners, LP | 6,117,530 shares, representing 16.3% of the class | |
| Tang Capital Management, LLC | 6,117,530 shares, representing 16.3% of the class | |
| Kevin C. Tang | 6,527,743 shares, representing 17.4% of the class | |
Follow Heron Therapeutics Inc. (NASDAQ:HRTX)
Follow Heron Therapeutics Inc. (NASDAQ:HRTX)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
